Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status

Roger S. Blumenthal, M. Imran Aslam, J. William McEvoy

Research output: Contribution to journalEditorialpeer-review

Fingerprint

Dive into the research topics of 'Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status <sup>∗</sup>'. Together they form a unique fingerprint.